Suppr超能文献

非甲状腺疾病患者的可溶性细胞因子受体与低三碘甲状腺原氨酸综合征

Soluble cytokine receptors and the low 3,5,3'-triiodothyronine syndrome in patients with nonthyroidal disease.

作者信息

Boelen A, Platvoet-Ter Schiphorst M C, Wiersinga W M

机构信息

Department of Endocrinology, University of Amsterdam, The Netherlands.

出版信息

J Clin Endocrinol Metab. 1995 Mar;80(3):971-6. doi: 10.1210/jcem.80.3.7883859.

Abstract

Cytokines have been implicated in the pathogenesis of the low T3 syndrome during illness. This is supported by our recent observation of a strong negative relationship between serum T3 and serum interleukin-6 (IL-6) in nonthyroidal illness (NTI). In the last few years, soluble cytokine receptors and cytokine receptor antagonists have been discovered in human serum. These proteins have the potential to further regulate cytokine activity. Therefore, we now studied the association between serum T3 and serum levels of soluble tumor necrosis factor-alpha (sTNF alpha R p55 and sTNF alpha R p75), soluble interleukin-2 receptor (sIL-2R), and the interleukin-1 receptor antagonist (IL-1RA) in 100 consecutive hospital admissions with a wide variety of nonthyroidal diseases. Patients were divided into group A (T3, > or = 1.30 nmol/L; T4, > or = 75 nmol/L; n = 41), group B (T3, < 1.30 nmol/L; T4, > or = 75 nmol/L; n = 46), and group C (T3, < 1.30 nmol/L; T4, < 75 nmol/L; n = 13). Serum sTNF alpha R p55, sTNF alpha R p75, sIL-2R, and IL-1RA were lower in group A than in groups B and C [median values; sTNF alpha R p55, 1.25, 2.25, and 3.55 ng/mL (P < 0.001); sTNF alpha R p75, 2.02, 4.56, and 7.00 ng/mL (P < 0.001); sIL-2R, 184, 259, and 272 U/mL (P = 0.0004), respectively]. Serum IL-1RA levels were not different in the three groups (median values, 122, 193, and 258 pg/mL, respectively). Taking all patients together, a significant negative relation was found among serum T3 and sTNF alpha p55 (r = -0.59; P < 0.0001), sTNF alpha R p75 (r = -0.55; P < 0.0001), sIL-2R (r = -0.54; P < 0.0001), IL-1RA (r = -0.38; P = 0.001), and IL-6 (r = -0.56; P < 0.0001). A remarkable high correlation (r = -0.70; P < 0.0001) was found between serum T3 and a newly designed total score based on the summation of serum levels of IL-6 and the four soluble cytokine receptor proteins. IL-6 and the four cytokine receptor proteins were all significantly related to each other. Stepwise multiple regression indicated IL-6 and sTNF alpha R p75 as independent determinants of T3 [serum T3 = 2.09-0.32ln (sTNF alpha R p75) -0.15ln (IL-6); r = 0.70]. The variability in serum T3 was accounted for 35% by changes in ln (sTNF alpha R p75) and 14% by changes in ln (IL-6).(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

细胞因子与疾病期间低T3综合征的发病机制有关。我们最近在非甲状腺疾病(NTI)中观察到血清T3与血清白细胞介素-6(IL-6)之间存在强烈的负相关关系,这支持了上述观点。在过去几年中,在人血清中发现了可溶性细胞因子受体和细胞因子受体拮抗剂。这些蛋白质有可能进一步调节细胞因子活性。因此,我们现在研究了100例因各种非甲状腺疾病连续入院患者的血清T3与可溶性肿瘤坏死因子-α(sTNFαR p55和sTNFαR p75)、可溶性白细胞介素-2受体(sIL-2R)以及白细胞介素-1受体拮抗剂(IL-1RA)血清水平之间的关联。患者被分为A组(T3≥1.30 nmol/L;T4≥75 nmol/L;n = 41)、B组(T3<1.30 nmol/L;T4≥75 nmol/L;n = 46)和C组(T3<1.30 nmol/L;T4<75 nmol/L;n = 13)。A组血清sTNFαR p55、sTNFαR p75、sIL-2R和IL-1RA低于B组和C组[中位数;sTNFαR p55分别为1.25、2.25和3.55 ng/mL(P<0.001);sTNFαR p75分别为2.02、4.56和7.00 ng/mL(P<0.001);sIL-2R分别为184、259和272 U/mL(P = 0.0004)]。三组血清IL-1RA水平无差异(中位数分别为122、193和258 pg/mL)。将所有患者综合考虑,发现血清T3与sTNFα p55(r = -0.59;P<0.0001)、sTNFαR p75(r = -0.55;P<0.0001)、sIL-2R(r = -0.54;P<0.0001)、IL-1RA(r = -0.38;P = 0.001)和IL-6(r = -0.56;P<0.0001)之间存在显著负相关。在血清T3与基于IL-6和四种可溶性细胞因子受体蛋白血清水平总和的新设计总分之间发现了显著的高相关性(r = -0.70;P<0.0001)。IL-6与四种细胞因子受体蛋白之间均显著相关。逐步多元回归表明IL-6和sTNFαR p75是T3的独立决定因素[血清T3 = 2.09 - 0.32ln(sTNFαR p75)- 0.15ln(IL-6);r = 0.70]。血清T3变异性的35%由ln(sTNFαR p75)的变化解释,14%由ln(IL-6)的变化解释。(摘要截于400字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验